CCDC153: A Potential Drug Target and Biomarker for Inflammatory Neurodegenerative Diseases

Target Name: CCDC153

NCBI ID: G283152

CCDC153

Other Name(s): Coiled-coil domain-containing protein 153 | CC153_HUMAN | Coiled-coil domain containing 153 | coiled-coil domain containing 153

CCDC153: A Potential Drug Target and Biomarker for Inflammatory Neurodegenerative Diseases

CDC153, also known as Coiled-coil domain-containing protein 153, is a protein that has been identified as a potential drug target and biomarker for several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Its unique structure, which consists of a long coiled-coil and a transmembrane domain, has led to a significant increase in its potential to interact with various signaling pathways and drug targets. In this article, we will provide a comprehensive overview of CDC153, its potential drug targets, and its potential as a biomarker for neurodegenerative diseases.

Potential Drug Targets

CDC153 has been shown to play a significant role in several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Its unique structure, which consists of a long coiled-coil and a transmembrane domain, has led to a significant increase in its potential to interact with various signaling pathways and drug targets.

One of the most promising potential drug targets for CDC153 is the tau protein. Tau is a protein that is involved in the formation of neurotransmitter receptors, which are critical for neurotransmission. Several studies have shown that tau can interact with CDC153 and that this interaction may play a role in the development and progression of neurodegenerative diseases.

Another potential drug target for CDC153 is the microglial cells, which are a type of immune cell that play a critical role in the immune response. Studies have shown that microglial cells can interact with CDC153 and that this interaction may play a role in the development and progression of neurodegenerative diseases.

Potential Biomarker

CDC153 has also been shown to serve as a potential biomarker for several neurodegenerative diseases. Its unique structure, which consists of a long coiled-coil and a transmembrane domain, has led to a significant increase in its potential to interact with various signaling pathways and drug targets. This increased interactivity may result in the production of biomarkers that can be used to diagnose and monitor neurodegenerative diseases.

One of the most promising biomarkers for CDC153 is the presence of tau in the brain. Studies have shown that the presence of tau in the brain is significantly associated with the development and progression of neurodegenerative diseases, including Alzheimer's disease. The presence of tau in brain tissue has also been used as a biomarker for Parkinson's disease and multiple sclerosis.

Another promising biomarker for CDC153 is the expression of CDC153 in the brain. Studies have shown that the expression of CDC153 is significantly increased in the brains of individuals with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This increased expression of CDC153 has also been used as a biomarker for neurodegenerative diseases.

Conclusion

In conclusion, CDC153 is a protein that has been identified as a potential drug target and biomarker for several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Its unique structure, which consists of a long coiled-coil and a transmembrane domain, has led to a significant increase in its potential to interact with various signaling pathways and drug targets. The potential drug targets for CDC153 include the tau protein and microglial cells, as well as the potential biomarker of the presence of tau in the brain. Further research is needed to fully understand the role of CDC153 as a drug target and biomarker for neurodegenerative diseases.

Protein Name: Coiled-coil Domain Containing 153

The "CCDC153 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC153 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets